We should get MHRA approval in the next 6 months, but let’s stay at above $2 for a week consistently, as a first hurdle. Then we will look forward to your $10 forecast through the rest of 2023! ;)
This scenario is especially realistic if you consider the possibility that approval from ANY RA would trigger a partnership with BP (read $MRK)... again, those Series C shares weren't created for nothing....(-: